Sustained hypoxia inhibits osteogenesis and osteoblast differentiation by downregulating the expression of runt-related transcription factor 2 (Runx2).
hypoxia alone is sufficient to suppress Runx2 expression in osteoblasts grown in standard tissue culture plates and, thus, leads to suppressed osteoblast differentiation. 3 Revealing bone-related pathology using the mechanism of osteoblast differentiation is problematic. 4, 5 Diverse molecules and signaling pathways have regulatory roles in osteoblast differentiation to various degrees, such as insulinlike growth factor-1, 6 p38 mitogen-activated kinases 7 and Janus-activated kinases/signal transducer and activator of transcription (STAT) pathways. 8, 9 However, Runx2 has a pivotal regulatory role in osteoblast differentiation because of posttranslational modifications. [10] [11] [12] In terms of Runx2-mediated regulation of osteoblast differentiation, other molecules and processes have been implicated. [12] [13] [14] Runx2 activity is regulated negatively by posttranslational modifications such as acetylation, phosphorylation, sumoylation, and ubiquitination. 11, 15 Suppressor of mothers against decapentaplegic (SMAD), STAT1, twist, and hey1 form complexes with Runx2, resulting in inhibition of osteoblast differentiation. 10, 15 Micro-RNAs (miRNAs) are a group of endogenous RNA molecules of size 18 to 25 nucleotides (nts). They have recently been recognized as regulating osteoblast differentiation via inhibition of expression of target genes during differentiation of MSCs to osteoblasts. Accumulating evidence suggests that certain miRNAs can regulate Runx2 expression and osteoblast differentiation, such as miRNA-451, 16 miRNA-455-5p, 17 and miRNA-133a-5p. 18 We wished to study miRNA regulation of osteoblast differentiation in response to hypoxia, and the association of miRNA expression with Runx2 expression. First, we profiled miRNA expression and measured Runx2 expression in hypoxia-treated mouse embryo osteoblast precursor (MC3T3-E1) cells. Then, we overexpressed the hypoxiaupregulated miRNA-21-5p and investigated its regulation of expression of Runx2 and other osteoblast differentiationassociated molecules. Our study provides a novel understanding of the role of miRNAs in the regulation of Runx2 expression and osteoblast differentiation.
| MATERIALS AND METHODS

| Cell culture and hypoxia treatment
MC3T3-E1 cells (American Type Culture Collection, Rockville, MD) were cultured with α-minimal essential medium (Invitrogen, Carlsbad, CA) containing 10% fetal bovine serum (Hyclone, Pittsburgh, PA) and 1% penicillin/streptomycin solution (Invitrogen). Cell culture was undertaken at 37°C with 18% CO 2 and 5% CO 2 in a humid incubator.
For hypoxia culture, a mixture of 5% CO 2 , 94% nitrogen and 1% oxygen was supplied to the incubator and monitored. To promote or downregulate cellular expression of miRNA-21-5p, 85%-confluent MC3T3-E1 cells in 12-or 24-well plates were transfected with miRNA-21-5p mimics (30 or 60 nM) or with a miRNA-21-5p inhibitor (20 or 40 nM) (scrambled RNA was taken as the control for miRNA-21-5p mimics or the inhibitor) with INTERFERin in a silent RNA transfection reagent (Polyplus Transfection, San Marcos, CA) according to the kit's manual. Scrambled RNA of equal concentration was taken as a negative control. To overexpress SMAD7, the SMAD7 coding sequence was cloned into a eukaryotic expression vector: pcDNA3.1(+). The recombinant SMAD7-pcDNA3.1(+) was transfected into MC3T3-E1 cells with lipofectamine 3000 (Invitrogen), and then the expression of the mRNA and protein of SMAD7 was measured. using β-actin as the internal control and presented as the mean ± SEM for three experiments carried out independently.
| Extraction and microarray analyses of miRNAs
| Western blot analysis
The protein expression of SMAD7, osteocalcin, P1NP, and Runx2 was examined by Western blot analysis. MC3T3-E1 cells were harvested by scratching and were lysed into icecold cell lysis buffer (Bio-Rad Laboratories, Hercules, CA). Cellular proteins were purified in the supernatant from cell debris after centrifugation at 12 000 × g for 15 minutes at 4°C. Protein samples were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis with 10% gels and transferred onto polyvinylidene difluoride (PVDF) membranes (Millipore, Bedford, MA). PVDF membranes were blocked with 5% skimmed milk powder overnight at 4°C. PVDF membranes were incubated with SMAD7-, osteocalcin-, P1NP-or Runx2-specific rabbit polyclonal antibodies F I G U R E 1 Upregulated and downregulated miRNAs in MC3T3-E1 cells under hypoxia. MC3T3-E1 cells were cultured under hypoxia or normoxia for 0, 6, 12, or 24 hours, and cellular miRNAs examined by qPCR. A-F, Relative levels of miR-145-5p (A), miR-21-5p (B), miR-9b-5p (C), miR-34a-3p (D), miR-146a-3p (E), miR-204-5p (F). Each of these miRNAs with >1.5-fold value change in the microarray. miRNA, microRNAs; qPCR, quantitative polymerase chain reaction. *P < 0.05, **P < 0.01, ***P < 0.001; ns, not significant, by the Student t-test (1:1000 dilution; Abcam, Cambridge, UK) in Tris-buffered saline adding Tween 20 (TBST) at 37°C for one h. Subsequently, they were incubated with secondary horseradish peroxidase-conjugated goat anti-rabbit IgG antibody (Bio-Rad Laboratories) for 30 minutes at 37°C. Finally, PVDF membranes were incubated with electrochemiluminescence solution (Thermo Fisher Scientific) and the specific protein bands were scanned by a Smart Chemi Lamp system (Thermo Fisher Scientific). PVDF membranes were washed three times with TBST before each incubation. The protein level of each marker was quantified according to the band density with β-actin as the loading control. Each value was averaged for three independent results.
| Luciferase reporting assay
We wished to examine target regulation by miRNA-21-5p on SMAD7 expression. We used the luciferase reporting assay with the reporter recombinant plasmids pLuc-SMAD7 3′-untranslated region (3′-UTR) and pLuc-SMAD7 3′-UTR (mutant) with the wild or mutated 3′-UTR of SMAD7. The paired sequences between miRNA-21-5p and 3′-UTR of SMAD7 were selected after alignment. The sequence of the wild and mutant 3′-UTR of SMAD7 was synthesized by SangonBio (Shanghai, China) and was inserted into the pCMVGLuc two vectors (New England Biolabs, Ipswich, MA) just downstream of the luciferase reporter. The recombinant plasmid pLuc-SMAD7 3′-UTR and pLuc-SMAD7 3′-UTR mut and miRNA-21-5p mimics were cotransfected into MC3T3-E1 cells for 24 hours. Relative luciferase activity was assayed with a Dual-Luciferase Assay kit (Promega, Madison, WI) by GloMax (Promega).
| Statistical analyses
Quantitative results are the mean ± SEM for three or more independent experiments. The Student t test analyzed the difference between two groups with Prism (GraphPad, La Jolla, CA). P < 0.05 was considered significant. Figure S1A ). These miRNAs ranged in length from 18 to 28 nts, without a significant difference in length between the two groups. We found 663 ± 94 miRNAs in both groups. 
| 16871
Among them, there were 10 miRNAs with > 1.5-fold higher, and 7 miRNAs with > 1.5-fold lower signals than those in hypoxia-treated cells ( Figure  S1B ). Quantified signals for the most-regulated 17 miRNAs are indicated in a "heatmap" ( Figure S1C ) for all four independent results. The heatmap demonstrated that 10 miRNAs (21-5p, 252a-5p, 9b-5p, 122-3p, 7a-5p, 200-5p, 181a-5p, 128a-5p, 210-5p, and 145-5p) were upregulated and 7 miRNAs (30b-3p, 146a-5p, 182-5p, 522-3p, 34a-5p, 204-5p, and 184b-5p) were downregulated. We also undertook qRT-PCR for significantly regulated (both upregulated) and downregulated) miRNAs. The significantly up-or downregulated miRNAs for two or more time points are . Each protein is presented as a relative level in comparison with β-actin (E). miRNA, microRNA; P1NP, procollagen type 1 amino-terminal propeptide; Runx2, runt-related transcription factor 2. *P < 0.05, **P < 0.01; ns, no significance indicated in Figure 1A -F (P < 0.05, 0.01 or 0.001 for 6, 12, or 24 hours posttreatment, respectively).
| Hypoxia-associated miRNA-21-5p
targets SMAD7 in hypoxia-treated MC3T3-E1 cells SMAD families have been hypothesized to be deregulated in response to hypoxia in multiple cell types. [20] [21] [22] We measured the expression of four types of SMADs (2, 3, 4, and 7) in hypoxia-or normoxia-treated MC3T3-E1 cells. Expression of SMAD3 and SMAD7 was downregulated significantly 12 hours and 24 hours after hypoxia (P < 0.05 or P < 0.01) (Figure 2A ). No significant difference was found between hypoxia and normoxia groups for SMAD2 or SMAD4. The downregulation on SMAD3 and SMAD7 was also observed in protein level by Western blot analysis ( Figure 2B ). miRNA-21-5p has been shown to regulate SMADs, 23 particularly SMAD7. 23, 24 To investigate the role of miRNA-21-5p on downregulation of SMAD7 expression by hypoxia, we blocked upregulation of miRNA-21-5p expression with a miRNA-21-5p-specific inhibitor in hypoxiatreated MC3T3-E1 cells ( Figure 2C ). Relatively higher SMAD7 expression was found in miRNA-21-5p inhibitortransfected cells under hypoxia (P < 0.05 or P < 0.01) ( Figure 2D ). Conversely, promotion of miRNA-21-5p expression via miRNA-21-5p mimicked transfection (P < 0.01) ( Figure 3A ) and reduced expression of SMAD7 mRNA (P < 0.01 or P < 0.001) ( Figure 3B ) and protein (P < 0.01 and P < 0.001) markedly ( Figure 3C ) in MC3T3-E1 cells. Also, according to the sequence alignment of miRNA-21-5p with the 3′-UTR of SMAD7, there were three highly homologous matching sites between them ( Figure 3D ). Next, we constructed luciferase reporter plasmids with these three highly homologous sequences to the 3′-UTR of SMAD7 or with the mutant sequences ( Figure 3E ). Figure 3F demonstrates targeted inhibition of luciferase activity by miRNA-21-5p mimics (30 or 60 nM) (P < 0.01 or P < 0.001), whereas significant regulation by the mimics was not observed when the mutated reporter was utilized. Thus, we showed that miRNA-21-5p downregulated SMAD7 expression by targeting its 3′-UTR in response to hypoxia in MC3T3-E1 cells. Control for SMAD7 overexpression (SMAD7 UP); miRNA, microRNA; mRNA, messenger RNA; P1NP, procollagen type 1 amino-terminal propeptide; Runx2, runt-related transcription factor 2; SMAD7, suppressor of mothers against decapentaplegic homolog 7. *P < 0.05, ***P < 0.001, ****P < 0.0001 miRNA-21-5p group. Western blot analysis confirmed no significant regulation by miRNA-21-5p on protein expression of osteocalcin or P1NP ( Figure 4D ,E). However, Runx2 expression was upregulated markedly in miRNA-21-5p-transfected MC3T3-E1 cells at 30 or 60 nM (P < 0.05 and P < 0.01) ( Figure 4D,E) . Next, we repeated experiments in hypoxia-treated MC3T3-E1 cells with or without SMAD7 overexpression. SMAD7 expression was upregulated significantly by SMAD7 overexpression at mRNA (P < 0.001) ( Figure 5A ) and protein ( Figure 5B ) levels under normoxia or hypoxia. Next, we measured the expression of Runx2 and P1NP in MC3T3-E1 cells: under normoxia; under hypoxia; with or without upregulation of miRNA-21-5p expression; with or without SMAD7 overexpression. Expression of Runx2 and P1NP was downregulated markedly by hypoxia in MC3T3-E1 cells ( Figure 5C ). However, upregulation of miRNA-21-5p expression attenuated such downregulation. Conversely, additional SMAD7 overexpression blocked such attenuation.
| DISCUSSION
miRNAs (eg, miRNA-21 family) have been shown to regulate osteoblast differentiation. In the present study, we demonstrated marked downregulation and upregulation of miRNA expression in MC3T3-E1 cells under hypoxia using qRT-PCR. miRNA-21-5p and miRNA-9b-5p showed the most significant upregulation of expression in hypoxiatreated MC3T3-E1 cells. miRNA-21-5p has been reported widely to be responsive to hypoxia, especially in hypoxic tumor microenvironments. 26, 27 miRNA-21-5p overexpression has also been verified to regulate osteoblast proliferation in vitro. 28 SMAD families have been suggested to be deregulated in response to hypoxia in multiple cell types. 28 In the present study, we found four types of SMADs (2, 3, 4, and 7) to be regulated differently by hypoxia in MC3T3-E1 cells. Expression of SMAD3 and SMAD7 was downregulated significantly in hypoxia-treated MC3T3-E1 cells. Recently, targeting of Smad7 by miR-21 and its family member, miR-590, has been reported by several reports. [29] [30] [31] Given the possible roles of miRNA-21-5p and SMADs in osteoblasts in response to hypoxia, we manipulated the miRNA-21-5p with mimics and an inhibitor of miRNA-21-5 and then investigated its wellrecognized target SMAD, SMAD7. Our results confirmed negative target regulation by miRNA-21-5p on SMAD7 expression in MC3T3-E1 cells under normoxia or hypoxia, as indicated by luciferase reporter with three predicted target sites. Interestingly, each of them (without repeats) was markedly less responsive to miR-21-5p. We speculated that miRNA-21-5p might be a protective marker in response to hypoxia in osteoblasts.
To link the hypoxia-responsive miRNA-21-5p with osteoblast differentiation, we measured the expression of the osteoblast differentiation-related markers Runx2, osteocalcin, and P1NP in hypoxia-treated MC3T3-E1 cells by upregulating or downregulating miRNA-21-5p expression. Interestingly, the mRNA expression of these markers was not regulated markedly by hypoxia. Only Runx2 expression was upregulated significantly by miRNA-21-5p overexpression. Moreover, such upregulation was associated with target regulation by miRNA-21-5p on SMAD and was blocked by SMAD7 overexpression. However, we could not exclude other Runx2-downregulation pathways under hypoxia. Our study just indicates the regulation on Runx2 by miRNA-21-5p/Smad7 pathway. It is hard to say what degree the endogenous miRNA-21-5p is responsible for the Runx2 protein level under the hypoxia condition.
| CONCLUSIONS
miRNA-21-5p can regulate markers of osteoblast differentiation, in association with its target inhibition of SMAD7 expression, in response to hypoxia in osteoblasts. Our study suggests that miRNA-21-5p might be a protective marker for osteoblast differentiation under hypoxia.
